Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2025-12-26 @ 3:03 AM
NCT ID:
NCT00855920
Pre Assignment Details:
Out of 747 participants, 225 were randomized and treated in the study. Participants were randomized in 1:1:1 ratio to receive one of the three treatment groups (Placebo \[for Rilonacept\] + Indomethacin or Rilonacept 320 mg + Indomethacin or Rilonacept 320 mg + Placebo \[for Indomethacin\]) on Day 1 of the study.
Recruitment Details:
The study was conducted at 80 study sites in North America between 16 March 2009 and 26 February 2010. A total of 747 participants were screened in the study.
Study:
NCT00855920
Study Brief:
Results Section:
NCT00855920